Vanta™ SCS Neurostimulator Recharge-free device
Vanta™ SCS gives you an advantage over pain. This high performance recharge-free device offers optimized longevity, DTM™ SCS endurance programming and unimpeded MRI access.*
Download Brochure
Overview
Product details
Vanta™ SCS is a high-performance recharge-free device offering optimised longevity
- Approximately 2x longer lasting than other devices at comparable settings1,2
- 5½–7½ years of recharge-free longevity estimated using actual 12-month DTM™ SCS endurance therapy programming data3
- In-app longevity estimator
DTM™ SCS endurance therapy
DTM™ SCS endurance therapy is an energy modified differential target multiplexed therapy offering meaningful pain relief, satisfaction, and quality of life improvements.4
Clinical evidence for DTM™ SCS endurance therapy4:
Meaningful pain relief
reduction in VAS for overall pain from baseline to 12 months
Quality of life improvements
of patients improved in degree of disability at 12-month follow up
Therapy satisfaction
of patients satisfied with therapy
Vanta™ has been enhanced for a better patient experience
Unmatched full-body
MRI access
- SureScan™ MRI technology allows MRI scans anywhere on the body* enabling diagnostic care.
- Provide patients the same access as non-implanted patients* — now and in the future.
- Shielded leads and proprietary device safeguards help patients safely get an MRI.*
- Access matters — 98% of patients are expected to need at least 1 MRI within 10 years of implant.5
Personalised programming
- AdaptiveStim™ technology automatically personalises therapy to maintain the optimal dose.
- 86.5% of patients reported better pain relief and/or convenience with AdaptiveStim™ technology over non-adaptive stimulation6.
- Exclusively offered by Medtronic.
Product specifications
Compatible with:
- MyStim™ PC smart patient therapy app model A72200
- Clinician programmer model CT900 with software app A71200 and trialing app A71300
- 16-electrode Specify™ SureScan™ MRI surgical leads
- Vectris™ SureScan™ MRI percutaneous leads
- INJEX™ anchoring system models 97791 and 97792
Model specifications
| Model | 977006 |
|---|---|
| Channels | 2 |
| Width | 1.1 cm (.44in) |
| Battery Type | Recharge-free |
*
Under specific conditions. Refer to product labeling for full list of conditions.
References
1
Settings used from Proclaim™ clinician manual. Nominal settings 12 hours per day: 50-Hz frequency, 225-μs pulse width, and 5-mA amplitude at 500-ohms impedance. Compared to flagship model 3660. Model 3670, ProclaimTM Plus, has same energy modeling as model 3660.
2
Settings from Boston Scientific’s Alpha IFU. Programmed at 4.1mA, 280us, 40 Hz, 1 area, 730 Ohms, 2 contacts.
3
Provenzano, Amirdelfan, Grewal, et al. Modeling Energy Demands of a Reduced-Energy Derivative of DTM™ Stimulation on Rechargeable and Recharge-Free SCS Systems. Poster presented at: American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Pain Medicine Meeting; Nov. 17-19, 2022; Orlando, FL, USA
4
Peacock J, Provenzano D, Fishman M, et al. Low energy Differential Target Multiplexed SCS derivative reduces pain and improves quality of life through 12 months in patients with chronic back and/or leg pain. Pain Pract. In press.
5
Desai MJ, Hargens LM, Breitenfeldt MD, et al. The rate of magnetic resonance imaging in patients with spinal cord stimulation. Spine. 2015;40(9):E531-537
6
Schultz D, Webster L, Kosek P, et al. Sensor-driven position-adaptive spinal cord stimulation for chronic pain. Pain Physician. 2012;15(1):1-12. 977006 Vanta Implant Manual M998494A001 Rev C
Brief Statement
This material should not be considered the exclusive source of information, it does not replace or supersede information contained in the device manual(s). Please note that the intended use of a product may vary depending on geographical approvals. See the device manual(s) for detailed information regarding the intended use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events. For a MRI compatible device(s), consult the MRI information in the device manual(s) before performing a MRI. If a device is eligible for eIFU usage, instructions for use can be found at Medtronic’s website manuals.medtronic.com. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser. Medtronic products placed on European markets bear the CE mark and the UKCA mark (if applicable).
For any further information, contact your local Medtronic representative and/or consult Medtronic’s websites.